Cellect Biotechnology Ltd. ADR | Balance Sheet
Fiscal year is January-December. All values ILS Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
4,044.00
13,379.00
11,742.00
30,936.00
27,733.00
4,765.90
Total Accounts Receivable
177.00
144.00
187.00
662.00
245.00
57.80
Other Current Assets
11.00
17.00
225.00
799.00
573.00
160.60
Total Current Assets
4,232.00
13,540.00
12,154.00
32,397.00
28,551.00
4,984.30
Net Property, Plant & Equipment
29.00
234.00
1,187.00
1,373.00
1,344.00
413.20
Total Investments and Advances
20.00
20.00
20.00
140.00
305.00
90.20
Long-Term Note Receivable
77.00
-
-
-
173.00
35.30
Total Assets
4,358.00
13,794.00
13,361.00
33,910.00
30,373.00
5,523
ST Debt & Current Portion LT Debt
-
-
-
58.00
-
Accounts Payable
-
-
466.00
1,343.00
1,703.00
Other Current Liabilities
600.00
835.00
2,394.00
2,084.00
2,396.00
Total Current Liabilities
600.00
835.00
2,860.00
3,485.00
4,099.00
Long-Term Debt
515.00
-
-
-
-
Other Liabilities
-
-
-
1,938.00
7,422.00
Total Liabilities
1,115.00
835.00
2,860.00
5,423.00
11,521.00
Common Equity (Total)
3,243.00
12,959.00
10,501.00
28,487.00
18,852.00
Total Shareholders' Equity
3,243.00
12,959.00
10,501.00
28,487.00
18,852.00
Total Equity
3,243.00
12,959.00
10,501.00
28,487.00
18,852.00
Liabilities & Shareholders' Equity
4,358.00
13,794.00
13,361.00
33,910.00
30,373.00
About Cellect Biotechnology
View Profile
